PharmaTher Holdings Ltd.
PHRRF
$0.179
$0.00734.25%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -14.19% | 5.48% | -16.91% | -30.46% | -6.95% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -20.66% | -64.07% | -76.75% | -65.92% | -49.02% |
| Operating Income | 20.66% | 64.07% | 76.75% | 65.92% | 49.02% |
| Income Before Tax | 4.37% | 65.53% | 72.25% | 77.48% | 51.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.37% | 65.53% | 72.25% | 77.48% | 51.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.37% | 65.53% | 72.25% | 77.48% | 51.69% |
| EBIT | 20.66% | 64.07% | 76.75% | 65.92% | 49.02% |
| EBITDA | 20.69% | 64.08% | 76.75% | 65.91% | 49.00% |
| EPS Basic | 6.45% | 65.91% | 72.57% | 77.44% | 50.79% |
| Normalized Basic EPS | 14.29% | 63.04% | 77.14% | 65.45% | 47.50% |
| EPS Diluted | 6.45% | 65.91% | 72.57% | 77.44% | 50.79% |
| Normalized Diluted EPS | 14.29% | 63.04% | 77.14% | 65.45% | 47.50% |
| Average Basic Shares Outstanding | 0.40% | 0.40% | 0.40% | 0.26% | 0.00% |
| Average Diluted Shares Outstanding | 0.40% | 0.40% | 0.40% | 0.26% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |